FDA Withdraws Authorization for Last Remaining COVID-19 Monoclonal Antibody Treatment December 2, 2022 Three drugs are still recommended for treatment, along with convalescent plasma. Read More
FDA Approves Ananda Scientific’s IND for CBD Drug Study December 1, 2022 The company believes the study can build upon the positive preclinical results for CBD. Read More
RSS
